Brief: Pharnext Reports FY Operating Revenues EUR 3.3 mln vs EUR 4.4 mln Last Year
12/04/2018 23:04
April 12 (Reuters) - Pharnext SA PHARN.PA :
* FY OPERATING REVENUES EUR 3.3 MILLION VERSUS EUR 4.4
MILLION
LAST YEAR
* OPERATING REVENUES FOR 2017 WERE MAINLY GENERATED BY
COMPANY'S
RESEARCH TAX CREDIT (EUR3.9M IN 2017) AND SUBSIDIES
Source text for Eikon: ID:nEQ9LtGZna
Further company coverage: PHARN.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development